Abstract: METHODS: We constructed a series of
HBx mutants with changes in the
CP region that correspond to
A1762T/
G1764A (TA),
T1753A,
T1768A, or a combination of these (combo) and expressed them, along with wild-type
HBx under control of its endogenous promoter, in primary human hepatocytes (PHHs) and HepG2 cells.
Introduction: Besides the TA mutation, other
core promoter mutations, notably
T1753V and
T1768A, have also been reported to be associated with an increased risk of
HCC.